DolCas Biotech's curcumin formulation targets sports nutrition sector
India, April 14 -- DolCas Biotech LLC's novel Curcugen curcumin formulation is being primed for the sports health sector. Newly armed with self-affirmed GRAS designation as a safe, functional food ingredient, Curcugen is poised to feature in a comprehensive portfolio of sports supplements and post-workout bars, shakes, and beverages. A new clinical study endorses Curcugen's role as a compelling post-workout anti-inflammatory agent.
Curcugen demonstrates anti-inflammatory role in acute exercise model
Results of clinical research published in the proceedings of the Seventeenth International Society of Sports Nutrition (ISSN) Conference and Expo, December 2020, confirmed Curcugen's positive anti-inflammatory, anti-oxidant and analgesic cap...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.